Charles River Laboratories International Inc.

NYSE:CRL   4:00:00 PM EDT
227.55
-2.54 (-1.10%)
5:04:12 PM EDT: $227.55 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)11.69B
Current PE24.33
Forward PE 20.63
2yr Forward PE 18.29
See more stats
Estimates Current Quarter
Revenue$991.64 Million
Adjusted EPS$2.06
See more estimates
10-Day MA$238.24
50-Day MA$252.25
200-Day MA$215.85
See more pivots

Charles River Laboratories International Inc. Stock, NYSE:CRL

251 Ballardvale Street, Wilmington, Massachusetts 01887
United States of America
Phone: +1.781.222.6000
Number of Employees: 21800

Description

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.